The knowns and unknowns of teprotumumab for thyroid eye disease

[ling]

thelancet.com/journals/land...

Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials

thelancet.com/journals/land...

[helvella Administrator Thyroid UK]

I am sorry that you do not appear to have received a timely response to your post/question - or perhaps you got an answer on another post or in a Private Message? Please feel free to post a new question if you wish. Posts are sometimes missed as it is so busy. Or maybe no-one who read it was able to answer?

Please do not feel the need to respond.

Thanks for posting - it is good to know that research continues.